Axorus
About:
Axorus is building a high acuity artificial retina for patients suffering from macular degeneration.
Website: http://www.axorus.com
Twitter/X: axorus
Top Investors: Eurasante, Finovam Gestion, Nord France Amorcage, Happy Capital
Description:
Axorus develops an artificial retina based on a high precision photoacoustic neurostimulator from Boston University.
Total Funding Amount:
1.2M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Loos, Nord-Pas-de-Calais, France
Founded Date:
2019-01-01
Contact Email:
contact(AT)axorus.com
Founders:
Clémence Cossec, Hélène Moulet, Jean-Damien Louise
Number of Employees:
1-10
Last Funding Date:
2020-07-17
IPO Status:
Private
Industries:
© 2025 bioDAO.ai